Westfield Capital Management
VRTX icon

Westfield Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,742
Closed -$702K 279
2024
Q4
$702K Buy
1,742
+470
+37% +$189K ﹤0.01% 223
2024
Q3
$592K Buy
1,272
+728
+134% +$339K ﹤0.01% 235
2024
Q2
$255K Buy
+544
New +$255K ﹤0.01% 247
2021
Q1
Sell
-652,910
Closed -$154M 286
2020
Q4
$154M Buy
652,910
+56,431
+9% +$13.3M 0.92% 24
2020
Q3
$162M Buy
596,479
+62,901
+12% +$17.1M 1.05% 19
2020
Q2
$155M Sell
533,578
-93,912
-15% -$27.3M 1.07% 20
2020
Q1
$149M Sell
627,490
-90,178
-13% -$21.5M 1.32% 14
2019
Q4
$157M Sell
717,668
-215,080
-23% -$47.1M 1.12% 21
2019
Q3
$158M Buy
932,748
+141,428
+18% +$24M 1.27% 18
2019
Q2
$145M Buy
791,320
+109,094
+16% +$20M 1.09% 19
2019
Q1
$125M Buy
682,226
+39,336
+6% +$7.24M 0.96% 22
2018
Q4
$107M Buy
642,890
+93,461
+17% +$15.5M 0.91% 22
2018
Q3
$106M Sell
549,429
-322,427
-37% -$62.1M 0.74% 37
2018
Q2
$148M Buy
871,856
+94,755
+12% +$16.1M 1.11% 18
2018
Q1
$127M Buy
777,101
+158,240
+26% +$25.8M 0.98% 23
2017
Q4
$92.7M Buy
+618,861
New +$92.7M 0.71% 40
2017
Q2
Sell
-355,880
Closed -$38.9M 285
2017
Q1
$38.9M Buy
+355,880
New +$38.9M 0.33% 106
2016
Q1
Sell
-4,495
Closed -$566K 295
2015
Q4
$566K Sell
4,495
-1,957,104
-100% -$246M ﹤0.01% 250
2015
Q3
$204M Buy
1,961,599
+1,750,058
+827% +$182M 1.45% 7
2015
Q2
$26.1M Buy
211,541
+36,784
+21% +$4.54M 0.16% 165
2015
Q1
$20.6M Sell
174,757
-109,901
-39% -$13M 0.12% 207
2014
Q4
$33.8M Sell
284,658
-4,228
-1% -$502K 0.2% 150
2014
Q3
$32.4M Buy
+288,886
New +$32.4M 0.2% 150